Interferon inducers increase O6-alkylguanine-DNA alkyltransferase in the rat liver

Carcinogenesis. 1990 Jan;11(1):181-3. doi: 10.1093/carcin/11.1.181.

Abstract

We investigated whether treatment with the interferon inducer polyinosinic-polycytidylic acid and other cytokines (interleukin-1, tumor necrosis factor) or the cytokine inducer lipopolysaccharide modified O6-alkylguanine-DNA alkyltransferase (AT) in rat liver. AT levels were determined in liver extracts using N-[3H]methyl-N-nitrosourea alkylated calf thymus DNA as substrate and an HPLC procedure to measure O6-methylguanine. Doses as low as 0.1 mg/kg i.p. of polyinosinic-polycytidylic acid caused a highly significant increase (P less than 0.01) in AT levels in the liver, evident either 24 or 48 h after treatment. Lipopolysaccharide at the dose of 80 micrograms/kg i.p. also induced AT whereas interleukin-1 (60 micrograms/kg) or tumor necrosis factor (60 micrograms/kg) were inactive. Treatment with human recombinant interferon alpha A/D caused a highly significant increase in AT levels, thus confirming the hypothesis that interferon was probably responsible for the observed effect. These results suggest a link between the immune response and DNA repair mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Enzyme Induction
  • Escherichia coli
  • Interferon Inducers / pharmacology*
  • Interferon Type I / pharmacology
  • Interleukin-1 / pharmacology
  • Lipopolysaccharides / pharmacology
  • Liver / drug effects
  • Liver / enzymology*
  • Male
  • Methyltransferases / biosynthesis*
  • O(6)-Methylguanine-DNA Methyltransferase
  • Poly I-C / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Recombinant Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Interferon Inducers
  • Interferon Type I
  • Interleukin-1
  • Lipopolysaccharides
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Methyltransferases
  • O(6)-Methylguanine-DNA Methyltransferase
  • Poly I-C